A retrospective study of predictive factors for unexpectedly prolonged or shortened progression-free survival and overall survival among patients with metastatic renal cell carcinoma who received first-line targeted therapy

BACKGROUND: To identify predictors of prolonged or shortened progression-free survival (PFS) and overall survival (OS) among patients with metastatic renal cell carcinoma (mRCC) who received first-line targeted therapies. METHODS: This retrospective study included 146 patients with mRCC who were tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sung Han, Kim, Sohee, Joo, Jungnam, Seo, Ho Kyung, Joung, Jae Young, Lee, Kang Hyun, Chung, Jinsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969738/
https://www.ncbi.nlm.nih.gov/pubmed/27484254
http://dx.doi.org/10.1186/s12885-016-2615-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969738/
https://www.ncbi.nlm.nih.gov/pubmed/27484254
http://dx.doi.org/10.1186/s12885-016-2615-4

Ejemplares similares